Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Topamax topiramate: Phase II data

In a 14-week, double-blind Phase II trial in 371 patients, Topamax reduced the percentage of

Read the full 156 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE